https://www.selleckchem.com/pr....oducts/dubs-in-1.htm
Brain volume loss (BVL) is commonly observed after high-dose immunosuppression and autologous hematopoietic cell transplantation (HDIT/HCT) for treatment of multiple sclerosis (MS). To better understand the mechanisms of underlying BVL associated with this treatment, we characterized the time courses of whole-brain (W, grey-matter (GM) and white-matter (WM) volume loss in relapsing-remitting MS (RRMS) patients who received BEAM-based HDIT/HCT. We used Jacobian integration to measure MRI-based WB, GM and WM volume changes up to 5year
Like
Comment
Share
